<DOC>
	<DOCNO>NCT00386425</DOCNO>
	<brief_summary>In trial , patient severe sepsis low protein C level receive drotrecogin alfa ( activate ) normal , approve dose time administration [ 24 microgram/kilogram/hour ( mcg/kg/hour ) 96 hour ] receive normal , approve dose high dos approve dose long administration time . After drug administration complete , protein C level patient receive normal , approve dose compare protein C level patient receive normal , approve dose high dose long duration determine protein C level improve faster give high dose and/or long administration time . Note : The protocol amend remove option short infusion duration .</brief_summary>
	<brief_title>Evaluate Protein C Levels Severe Sepsis Patients Drotrecogin Alfa ( Activated )</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Drotrecogin alfa activate</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Must 18 year old Must suspect proven infection Must two sepsisassociated organ dysfunction Documented multiple organ dysfunction great 24 hour prior start study drug Actual body weight less 30 kg 135 kg Platelet count le 30,000/mm^3 Active internal bleeding increase risk bleed Not expect survive 28 day give patient 's preexisting uncorrectable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>